In our recent Bayesian analysis paper, false-negative results were compared between Lyme disease and HIV using a recommended test algorithm.[@b1-ijgm-10-291] When the two-tier test methodology for Lyme disease was compared with HIV two-stage testing, false negatives could be more than 500 times higher for Lyme disease testing.

The two-stage HIV test was designed to be used if an initial test was negative and there was symptomatic or subjective evidence that HIV infection could be present. The method reduces the chance of negative results resulting from determinate or random errors encountered in sampling and medical laboratory practice.

Based on the very high sensitivity and specificity of HIV tests, an updated methodology recommends that a second test of negative samples should not be carried out.[@b2-ijgm-10-291] A second test is recommended for positive samples, not as a two-tier confirmatory test as with Lyme disease but to identify the HIV-1 or HIV-2 antibody/antigen type.

The last column of [Table 1](#t1-ijgm-10-291){ref-type="table"} demonstrates that when false-negative tests are compared between the two-tier test for Lyme disease and a single HIV test, false negatives are still up to more than 500 times higher for Lyme disease testing.
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###### 

Comparison of false-negative probabilities for LD and HIV testing: clinical samples

                       LD testing (test dependence 0.63)   HIV disease testing (test dependence 0.950)   False negative ratio                                                   
  -------------------- ----------------------------------- --------------------------------------------- ---------------------- ------- ------- ------- -------- -------- ----- -----
  Acute                20.4%                               21.2%                                         79.6%                  85.6%   98.6%   98.6%   1.40%    1.33%    64    61
  Early intermediate   30.4%                               31.5%                                         69.6%                  77.3%   98.9%   98.9%   1.10%    1.05%    74    70
  Convalescent         37.2%                               38.6%                                         62.8%                  71.3%   99.4%   99.4%   0.60%    0.57%    125   119
  Late intermediate    45.5%                               47.3%                                         54.5%                  63.3%   99.7%   99.7%   0.30%    0.29%    222   211
  Neuro/arthritis      53.1%                               55.2%                                         46.9%                  55.7%   99.9%   99.9%   0.100%   0.095%   586   557

**Abbreviations:** LD, Lyme disease; Neuro, neurological.
